Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review

Charles S. Mayo, Thomas M. Pisansky, Ivy A. Petersen, Elizabeth S. Yan, Brian J. Davis, Scott L. Stafford, Yolanda I. Garces, Robert C. Miller, James A. Martenson, Robert W. Mutter, Richard Choo, Christopher L. Hallemeier, Nadia N. Laack, Sean S. Park, Daniel J. Ma, Kenneth R. Olivier, Sameer R. Keole, Mirek Fatyga, Robert L. Foote, Michael G. Haddock

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Introduction: Establishment of standards within a practice and across disease site groups for nomenclatures, prescription formatting, and measured dose-volume histogram (DVH) metrics is a key enabling step for creating software and database solutions to make routine aggregation of dosimetric data for all patients treated in a practice, practical. A process of physician-driven, iterative dialogs coupled with development of technical tools is required to implement the cultural and procedural changes. The cumulative reward for this effort is a database that can be used for defining practice norms, benchmarking against national standards, and tracking dosimetric effects of longitudinal practice pattern changes. Methods and materials: A 4-year project was carried out to develop and introduce standardizations, modify processes, and develop computer-based tools for reporting, aggregation, and analysis of prescription and DVH metrics. Physician disease site groups developed 42 target and 81 normal tissue templates. From the database of 32,002 DVH metrics, benchmarking was illustrated for a subgroup of breast (281) and prostate (324) patients treated with conventional fractionation over a 16-month period. Breast patients were segregated according to prescription template used: simple (S, tangents only) vs complex (C, tangents + supraclavicular ± intramammary nodes) and left (S-L or C-L) versus right (S-R or C-R). Results: Prostate patients' median and 50% confidence intervals (CIs) for bladder, stated according to the nomenclature: the percentage of bladder volume receiving doses of ≥. 40 Gy (V40[%]), V65Gy[%], V70Gy[%], V75Gy[%], and V80Gy[%] were 45.5 (24.9-57.0), 15.6 (9.0-23.8), 7.6 (3.3-13.6), 2.0 (0.0-7.9), and 0.0 (0.0-1.4), respectively. Values for rectum: V50Gy[%], V60 Gy[%], V65Gy[%], V70Gy[%], and V75Gy[%] were 37.1 (27.8-43.5), 21.8 (15.6-25.5), 14.6 (9.6-18.0), 7.7 (1.9-12.3), and 1.0 (0-7.0), respectively. For breast patients, heart:mean Gray values were 1.5 (1.0-2.0), 3.1 (2.2-4.8), 0.4 (0.3-0.7), and 1.1 (0.8-2.2) for S-L, C-L, S-R, and C-R, respectively. Longitudinal, moving window plots of median, 50% CI, and 90% CI for 6-month periods demonstrated the effect of practice changes to reduce heart doses. Conclusions: Standardization was challenging as a practice change, but has resulted in significant improvements for both our clinical and research efforts.

Original languageEnglish (US)
Pages (from-to)e117-e126
JournalPractical Radiation Oncology
Issue number4
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review'. Together they form a unique fingerprint.

Cite this